New Zealand markets closed

Hillstream BioPharma, Inc. (HILS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4389+0.0089 (+2.07%)
At close: 04:00PM EST
0.4150 -0.02 (-5.45%)
After hours: 07:38PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 5.60M
Enterprise value 7.76M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.71
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.23

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-87.93%
S&P500 52-week change 3-15.72%
52-week high 34.2400
52-week low 30.3500
50-day moving average 30.5871
200-day moving average 31.0243

Share statistics

Avg vol (3-month) 353.61k
Avg vol (10-day) 3119.43k
Shares outstanding 511.53M
Implied shares outstanding 6N/A
Float 83.89M
% held by insiders 155.50%
% held by institutions 16.28%
Shares short (14 Nov 2022) 430.7k
Short ratio (14 Nov 2022) 40.71
Short % of float (14 Nov 2022) 40.42%
Short % of shares outstanding (14 Nov 2022) 40.27%
Shares short (prior month 13 Oct 2022) 46.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-79.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-4.25M
Diluted EPS (ttm)-0.3910
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.6M
Total cash per share (mrq)0.66
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.93
Book value per share (mrq)0.62

Cash flow statement

Operating cash flow (ttm)-5.5M
Levered free cash flow (ttm)-6.48M